Sources Eli Lilly press release TRIUMPH-1 Phase 3 topline results, May 21, 2026 Eli Lilly press release TRIUMPH-4 Phase 3 trial results, December 2025 Eli Lilly press release TRANSCEND-T2D-1 topline results, March 19, 2026 Bajaj HS et al
The same association may be observed in women (109)
The active ingredient (tirzepatide) is the same molecule, but the final product is not FDA-approved, has not undergone clinical trials, and contains an additional ingredient
There is no established human dosing , and clinical evidence remains limited
At the same time, abstinence will remain a goal for many people, and these medications will make that goal far more achievable
Grape Seed Extract Grape seed extract (GSE) has been shown to improve liver health, which is intimately related to metabolic health and often dysregulated in type 2 diabetes